Full Press Release Details
Ultragenyx to Participate in Gene Therapy Panel at Wedbush PacGrow Healthcare Conference.
RARE
Ultragenyx to Participate in Gene Therapy Panel at Wedbush PacGrow Healthcare Conference
Key Takeaway: Ultragenyx to Participate in Gene Therapy Panel at Wedbush PacGrow Healthcare Conference
Price reaction · baseline $83.77 (2021-08-03 close) · hit after-hours · clean, no other RARE news in the window
day 0 close · peak
+2%
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+43%
120-day peak, hindsight
Typical move
2.9%
average across 6 past catalysts
Cash runway
~13 mo
Low dilution risk
Lead asset
BPS804
Phase 2 · Hypophosphatasia